Species-dependent structural polymorphism of Y145Stop prion protein amyloid revealed by solid-state NMR spectroscopy

Theint Theint1, Philippe S Nadaud1, Darryl Aucoin1

  • 1Department of Chemistry and Biochemistry, The Ohio State University, Columbus, OH, 43210, USA.

Nature Communications
|October 1, 2017
PubMed

Insights

Two amino acids control prion protein amyloid structure and species barriers. This finding in human, mouse, and hamster prion diseases offers insights into prion propagation and strain diversity.

Area of Science:

  • Biochemistry
  • Structural Biology
  • Neuroscience

Background:

  • Prion diseases exhibit complex strain variations and interspecies transmission barriers.
  • Prion protein (PrP) strain phenomena and species barriers can be modeled in vitro using seeded fibrillization of the Y145Stop PrP variant.

Purpose of the Study:

  • To investigate the atomic-level structural differences in Y145Stop prion protein amyloids across species.
  • To identify the key molecular determinants governing prion strain structure and interspecies transmissibility.

Main Methods:

  • Solid-state nuclear magnetic resonance (ssNMR) spectroscopy was employed.
  • Comparative structural analysis of Y145Stop prion protein amyloids from human, mouse, and Syrian hamster.

Main Results:

  • Structural variations in Y145Stop PrP amyloids are primarily dictated by two amino acid residues at positions 112 and 139.
  • These specific residues function as conformational switches, influencing amyloid strain formation.
  • A model for human Y145Stop PrP amyloid was developed, explaining cross-seeding specificity.

Conclusions:

  • Two key amino acid residues are critical for determining prion protein amyloid structure and interspecies transmissibility.
  • Understanding these residue roles provides a molecular basis for prion strain diversity and cross-species propagation.
  • This research lays the groundwork for comprehending prion disease mechanisms and developing targeted interventions.